发布求助
文献互助 智能选刊 最新文献

Recenti progressi in medicina最新文献

筛选
英文 中文
Towards artificial intelligence application in pain medicine. 浅谈人工智能在疼痛医学中的应用。
Recenti progressi in medicina Pub Date : 2025-03-01 DOI: 10.1701/4460.44555
Marco Cascella, Matteo L G Leoni, Mohammed Naveed Shariff, Giustino Varrassi
{"title":"Towards artificial intelligence application in pain medicine.","authors":"Marco Cascella, Matteo L G Leoni, Mohammed Naveed Shariff, Giustino Varrassi","doi":"10.1701/4460.44555","DOIUrl":"10.1701/4460.44555","url":null,"abstract":"<p><p>Pain is a complex, multidimensional experience involving significant challenges in both diagnosis and management. While acute pain serves as a critical warning mechanism, chronic pain encompasses intricate biological, psychological, and social components, complicating its assessment and treatment. Artificial intelligence (AI) technologies are revolutionizing medicine and healthcare. Here we present an overview of the recent advances in AI for pain medicine. For example, the emergence of automatic pain assessment (APA) methodologies offers promising avenues for more objective pain evaluation. For APA aims, AI technologies, including machine learning algorithms and deep learning architectures such as natural language processing systems, have shown potential in analyzing biosignals, facial expressions, and speech patterns related to pain. However, the integration of these objective measures with traditional self-reporting remains essential for a comprehensive approach to pain diagnosis. Notably, APA models can be implemented for pain diagnosis in newborn and non-communicative patients. Additionally, the application of AI extends beyond pain diagnosis to personalized treatment strategies, predict opioid use disorders, education and training, clinical trajectory definition, and telehealth and real-time. Despite the potential of these innovations, challenges such as validation, parameter selection, and ethical aspects of technical implementation must be addressed.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 3","pages":"156-161"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carlo Alfredo Clerici, pioniere del legame tra spiritualità e cura. 卡洛·阿尔弗雷多·克莱西，灵性和治疗之间联系的先驱。
Recenti progressi in medicina Pub Date : 2025-03-01 DOI: 10.1701/4460.44565
Marco Dotti
{"title":"Carlo Alfredo Clerici, pioniere del legame tra spiritualità e cura.","authors":"Marco Dotti","doi":"10.1701/4460.44565","DOIUrl":"10.1701/4460.44565","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 3","pages":"199-200"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143625753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[In adults with knee osteoarthritis, methotrexate offers minimal pain relief.] [对于患有膝骨关节炎的成人，甲氨蝶呤能提供最小程度的疼痛缓解。]
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44444
Peter K Kurotschka, Allen F Shaughnessy, Alice Serafini
{"title":"[In adults with knee osteoarthritis, methotrexate offers minimal pain relief.]","authors":"Peter K Kurotschka, Allen F Shaughnessy, Alice Serafini","doi":"10.1701/4450.44444","DOIUrl":"10.1701/4450.44444","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"120-121"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Successfully treatment with axicabtagene ciloleucel of a female patient with an early relapsed diffuse large B-cell lymphoma.] 【艾卡他格西鲁塞治疗早期复发的弥漫大b细胞淋巴瘤1例成功】
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44452
Renato Scalone
{"title":"[Successfully treatment with axicabtagene ciloleucel of a female patient with an early relapsed diffuse large B-cell lymphoma.]","authors":"Renato Scalone","doi":"10.1701/4450.44452","DOIUrl":"10.1701/4450.44452","url":null,"abstract":"<p><p>Refractoriness and early relapse after first-line therapy are two high-risk conditions for patients with diffuse large B-cell lymphoma (DLBCL). Nowadays, axicabtagene ciloleucel (axi-cel) is the therapeutic strategy to adopt in these clinical conditions, considering the results obtained in terms of overall survival and progression free survival in the ZUMA-7 trial. In the clinical case here reported, a female patient with an early relapsed triple expressor DLBCL was successfully treated with axi-cel, obtaining the complete remission at one month from therapy. Similarly, the adverse events onset after axi-cel were successfully and quickly treated.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"e33-e35"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Numeri in questo numero
2025 Febbraio. 这个数字是2025年2月。
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44434
{"title":"Numeri in questo numero<br>2025 Febbraio.","authors":"","doi":"10.1701/4450.44434","DOIUrl":"10.1701/4450.44434","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"59"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The first Italian patient affected by diffuse large B-cell lymphoma treated with axi-cel in the second line: innovation and tradition.] 【意大利首例弥漫性大b细胞淋巴瘤患者行轴细胞二线治疗：创新与传统】
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44450
Stefania Bramanti, Davide Chizzoniti, Daniele Mannina
{"title":"[The first Italian patient affected by diffuse large B-cell lymphoma treated with axi-cel in the second line: innovation and tradition.]","authors":"Stefania Bramanti, Davide Chizzoniti, Daniele Mannina","doi":"10.1701/4450.44450","DOIUrl":"10.1701/4450.44450","url":null,"abstract":"<p><p>CAR-T cell therapy has revolutionized the treatment of refractory or relapsed diffuse large B-cell lymphoma (DLBCL) within 12 months, replacing the use of high-dose chemotherapy with autologous stem cell reinfusion. Primary chemoresistance remains one of the most unfavorable prognostic scenarios for patients with DLBCL, despite the progress made with the introduction of anti-CD20 monoclonal antibodies in first-line treatment. Early identification of prognostic factors associated with clinical presentation represents an integrated approach that ensures rapid access to autologous anti-CD19 CAR-T therapy in selected cases that may benefit from treatment according to current standard indications.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"e24-e27"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dalla letteratura
2025 Febbraio. 2025年2月。
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44435
{"title":"Dalla letteratura<br>2025 Febbraio.","authors":"","doi":"10.1701/4450.44435","DOIUrl":"10.1701/4450.44435","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"61-64"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Routine Ecg screening: limited value for evaluating cardiovascular risk in working-age adults.] 【常规心电图筛查：评估工作年龄成人心血管风险的价值有限】
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44445
Viviana Forte, Allen F Shaughnessy, Peter K Kurotschka
{"title":"[Routine Ecg screening: limited value for evaluating cardiovascular risk in working-age adults.]","authors":"Viviana Forte, Allen F Shaughnessy, Peter K Kurotschka","doi":"10.1701/4450.44445","DOIUrl":"10.1701/4450.44445","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"122-123"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[From modern science to open science, publishing in the scientific field: copyright, Creative Commons and… beyond.] [从现代科学到开放科学，科学领域的出版：版权、知识共享等。]
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44437
{"title":"[From modern science to open science, publishing in the scientific field: copyright, Creative Commons and… beyond.]","authors":"","doi":"10.1701/4450.44437","DOIUrl":"10.1701/4450.44437","url":null,"abstract":"<p><p>The concept of copyright protection emerged and developed throughout history to promote the widest dissemination of information. After two centuries of its establishment, development, and maturation, the traditional system entered a full-blown crisis, undermined at its foundations by digital innovation and the socio-cultural transformation of the 20th century. This evolution, marked by continuous adaptations, has introduced elements that are currently limiting the free circulation of scientific knowledge and hindering access to information. Creative Commons (CC) licenses offer a more flexible model for managing copyright, allowing authors to reserve some rights while relinquishing others. There are different variants of CC licenses, ranging from simple attribution (CC BY) to restrictions on commercial use and derivative works (CC BY NC ND). These licenses have been used both to promote the openness of resources and to perpetuate their commercial or paid distribution. For a significant shift towards more open science, a rebalancing of power is needed among authors, publishers, and users, with greater awareness of their rights by those who play a key role in scientific production.</p>","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"69-76"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ogni maledetta domenica (i bianchi e i verdi). 每个该死的星期天。
Recenti progressi in medicina Pub Date : 2025-02-01 DOI: 10.1701/4450.44447
Vittorio Fontana
{"title":"Ogni maledetta domenica (i bianchi e i verdi).","authors":"Vittorio Fontana","doi":"10.1701/4450.44447","DOIUrl":"10.1701/4450.44447","url":null,"abstract":"","PeriodicalId":20887,"journal":{"name":"Recenti progressi in medicina","volume":"116 2","pages":"126"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143391622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信